ResMed RMD Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.52B+2.3% | $1.49B+3.3% | $1.44B+2.7% | $1.4B+6.7% | $1.31B+5.2% | ||
| $220.19M+7.5% | $204.89M+1.7% | $201.44M+1.5% | $198.47M+11.2% | $178.52M+0.1% | ||
| $101.64M+2.7% | $98.97M+6.8% | $92.67M+1.1% | $91.66M+3.8% | $88.3M+4.3% | ||
| $64.78M-26.3% | $87.96M+5.8% | $83.13M+8.4% | $76.68M-40.6% | $128.99M-11.3% | ||
| $8.19M— | —— | —— | —— | —— | ||
| $171.25M+31.3% | $130.46M+5.2% | $124.03M+36.4% | $90.96M-44.5% | $163.85M+20.3% | ||
| $105.39M+573% | -$22.3M+73.8% | -$85.06M-2.9% | -$82.63M-326% | -$19.38M-123% | ||
| —— | —— | -$15.81M-53.5% | -$10.3M+55.7% | -$23.24M-533% | ||
| $43.13M+4.4% | $41.31M+7.8% | $38.33M+2.7% | $37.34M-1.1% | $37.76M-7.2% | ||
| —— | —— | —— | $3.64M+60.5% | $2.27M+153% | ||
| $1.89B-1.3% | $1.91B+1.7% | $1.88B+7.5% | $1.75B+6.0% | $1.65B+12.0% | ||
| $135.74M+10.5% | $122.89M+6.9% | $114.99M+28.0% | $89.87M+6.8% | $84.16M-0.5% | ||
| —— | —— | $139.77M+0.4% | $139.25M+584% | $20.37M-13.1% | ||
| $28.55M+173% | $10.47M+44.6% | $7.24M+12.8% | $6.42M-14.2% | $7.48M-4.3% | ||
| $3M+500% | $500K0.0% | $500K-89.2% | $4.63M-9.8% | $5.13M— | ||
| —— | —— | $11.82M+9.7% | $10.78M+647% | $1.44M-57.1% | ||
| -$295.26M-9.8% | -$269.02M-5.6% | -$254.77M-27.4% | -$200.05M-77.3% | -$112.84M+1.2% | ||
| $340.16M+2.9% | $330.63M+3.1% | $320.74M+3.2% | $310.88M+2.3% | $303.84M+2.4% | ||
| $600.05M+20.0% | $500.06M+25.0% | $400.03M+33.3% | $300.03M+20.0% | $250.02M+11.1% | ||
| —— | $10M0.0% | $10M-75.0% | $40M-88.1% | $335M-39.6% | ||
| $75.35M-2.1% | $76.94M+3.6% | $74.26M-0.2% | $74.44M+3.4% | $71.98M+6.1% | ||
| $22.04M+0.2% | $21.98M+19.4% | $18.41M+1.8% | $18.08M+0.9% | $17.91M+0.3% | ||
| -$907.75M-14.0% | -$796.58M-16.2% | -$685.77M-13.1% | -$606.25M+27.5% | -$835.65M+18.7% | ||
| $40.85M-11.6% | $46.23M+215% | $14.66M-43.2% | $25.8M+364% | -$9.77M+57.6% | ||
| $727.8M-18.7% | $895.13M-6.5% | $957.49M-1.4% | $971.09M+39.8% | $694.8M+123% | ||
| $26.91M-22.2% | $34.6M+23.6% | $27.98M-1.8% | $28.48M+3.6% | $27.49M+13.1% | ||
| $297.27M— | —— | —— | —— | —— | ||
| —— | —— | -$15.81M-53.5% | -$10.3M+55.7% | -$23.24M-533% | ||
| $5.99M+30.0% | $4.61M+10.5% | $4.17M+14.4% | $3.64M— | —— | ||
| —— | —— | —— | $3.64M+60.5% | $2.27M+153% | ||
| $105.39M+573% | -$22.3M+73.8% | -$85.06M-2.9% | -$82.63M-326% | -$19.38M-123% | ||
| —— | —— | —— | $0— | $0— | ||
| $43.13M+4.4% | $41.31M+7.8% | $38.33M+2.7% | $37.34M-1.1% | $37.76M-7.2% | ||
| —— | —— | —— | —— | —— | ||
| -$47.97M— | —— | —— | —— | —— | ||
| —— | —— | $139.77M-0.2% | $140.1M+560% | $21.22M-12.7% | ||
| —— | —— | $11.82M+9.7% | $10.78M+647% | $1.44M-57.1% | ||
| $3M+500% | $500K0.0% | $500K-89.2% | $4.63M-9.8% | $5.13M— | ||
| —— | —— | —— | $10.86M+33.3% | $8.14M+50.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $0-100% | $8.31M-50.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $670K+334% | -$286K+33.3% | ||
| —— | —— | $102.64M+1.3% | $101.32M+600% | $14.48M0.0% | ||
| $297.27M— | —— | —— | —— | —— | ||
| —— | —— | $42.74M-1.8% | $43.53M+479% | $7.51M0.0% | ||
| $1.75B-2.1% | $1.79B+1.3% | $1.77B+6.4% | $1.66B+5.9% | $1.57B+12.7% | ||
| $1.75B-2.1% | $1.79B+1.3% | $1.77B+6.4% | $1.66B+5.9% | $1.57B+12.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
